2006
DOI: 10.1148/radiol.2382041993
|View full text |Cite
|
Sign up to set email alerts
|

PET with FDG-labeled Leukocytes versus Scintigraphy with111In-Oxine–labeled Leukocytes for Detection of Infection

Abstract: PET with FDG-labeled leukocytes was comparable to scintigraphy with (111)In-oxine-labeled leukocytes. Further investigation in a larger population with dedicated PET or PET/computed tomography seems warranted.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

3
72
0
3

Year Published

2009
2009
2021
2021

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 86 publications
(78 citation statements)
references
References 8 publications
3
72
0
3
Order By: Relevance
“…The most frequent cause, aseptic loosening, is an inflammatory reaction to the prosthetic components (1). Subsequently, the particulate debris activates tissue phagocytes but cannot be broken down by cellular enzymes.…”
Section: Discussionmentioning
confidence: 99%
“…The most frequent cause, aseptic loosening, is an inflammatory reaction to the prosthetic components (1). Subsequently, the particulate debris activates tissue phagocytes but cannot be broken down by cellular enzymes.…”
Section: Discussionmentioning
confidence: 99%
“…Although the results obtained were satisfactory, there are considerable, likely insurmountable, limitations to this test. The labeling efficiency of 18 F-FDG leukocytes is more variable and significantly lower than that of 111 In-oxine leukocytes (2,17). The stability of the label is poor.…”
mentioning
confidence: 97%
“…Initial attempts at developing a more specific PET tracer for infection imaging focused on labeling leukocytes in vitro with 18 F-FDG (17,18). Although the results obtained were satisfactory, there are considerable, likely insurmountable, limitations to this test.…”
mentioning
confidence: 99%
“…[ 18 F]-FDG has routinely been used to assess tissue metabolism. As assessed by PET, reductions in glucose metabolism have been noted in Alzheimer's disease and mild cognitive impairment [17] and the hypometabolism is believed to be associated with reduced neuronal activity and neuronal loss [18,19]. If the growth retardation and altered metabolism is associated with tissue hypoxia, [ 18 F]fluoromisonidazole ([ 18 F]FMISO) [20] is a selective measure for assessing hypoxia.…”
mentioning
confidence: 99%